Oura Challenges Whoop with Labs

This matters because blood testing turns the Oura and Whoop fight from a wearable comparison into a battle over who owns the full consumer health loop. Both now pair daily sensor data with Quest blood draws and clinician review, so the product is no longer just sleep scores or recovery scores. It is becoming a place to buy a test, see results in the app, and connect those lab markers to patterns in training, food, sleep, and stress.1 2 3 4 5

• Oura Health Panels lets members book testing through Quest, track 50 biomarkers, and see results inside the Oura app. That pulls Oura beyond ring data into a more clinical workflow, where the app becomes a health dashboard instead of only a recovery tracker.1 2 3
• Whoop Advanced Labs uses the same basic wedge, Quest based bloodwork tied back to continuous wearable data. Whoop has pushed further on monetization with annual plans from $199 to $599 and later added one time specialized panels for heart, metabolic, performance, and sex specific testing.4 5 6
• The overlap is strategic because Oura and Whoop are already close on scale and funding. Oura was valued at $11B after its 2025 Series E, while Whoop reached a $10.1B valuation in its 2026 Series G. Once both sell labs, the contest shifts to which app best turns raw biomarkers into sticky habits and recurring spend.8

The next step is a broader preventive health bundle. Wearables will keep moving from passive tracking into repeat testing, coaching, and condition specific programs. The winner is likely to be the company that makes bloodwork feel like a natural extension of weekly product use, not a separate medical errand.1 4 6